China Factory Peptide Synthesis Vials Lyophilized Peptides Powder PE 22-28 10mg PE10

• WhatsApp: +852 9335 4794
  
  
  Email: 15030963274@163.com

PE 22-28  High Purity API Intermediate (CAS: 1801959-12-5) is a key heterocyclic synthetic intermediate dedicated to laboratory pharmaceutical synthesis research. The product adopts full-enclosed low-temperature synthesis, multi-stage recrystallization purification and vacuum drying process, effectively removing residual catalysts, unreacted raw materials and heavy metal impurities. The finished product presents uniform white crystalline solid, with HPLC single-point purity ≥99%, each single unknown impurity less than 0.1%, total impurities controlled below 1.0%. The whole production line follows laboratory chemical raw material quality control standards, strictly limits heavy metal, microbial and endotoxin residues, greatly reducing interference in subsequent synthetic route trials and ensuring stable yield and repeatability of multi-step API synthesis experiments. Its unique heterocyclic molecular skeleton can participate in multiple coupling and cyclization reactions, widely applied in novel small-molecule drug route exploration, pharmaceutical process optimization, intermediate structure modification and compound library construction for academic research labs and pharmaceutical R&D institutions.

• We offer various types of peptides, about peptides, we can offer good quality, good price. Customers who have ordered our products (peptides) have received very good feedback. Reliable buyers around the world can contact us about peptides

  1. Ultra-low temperature freezing: Freeze the highly active ingredients at -196 degrees to put the active ingredients into a dormant state.

  2. Effective regeneration: Add the solvent to the powder when using it, and it can be effectively regenerated after mixing, ensuring the high activity and high stability of the product. We offer various types of peptides, and we can provide excellent quality and preferential prices for peptides. The feedback from customers who have ordered our products (peptides) is very good. Reliable buyers around the world can contact us for peptide matters. We offers an unparalleled combination of quality, performance and value. If you have any questions about this product or want to learn more about how it can benefit your business, please feel free to contact us. We are committed to providing excellent customer service and helping our customers achieve their business goals.We look forward to the opportunity to work with you and help you succeed.

           Research Compliance Statement: This article is for reference only in university laboratories, biomedical research and development, and in vitro and animal model studies, and does not constitute a guide for medical or human use. This article is for research purposes only.

P41 is a synthetic melanocortin receptor-targeting peptide. The finished product is a white lyophilized powder with HPLC purity ≥99% and good water solubility. Storage conditions: -20℃, protected from light and sealed. The dry powder has excellent stability. It is recommended to aliquot the prepared aqueous solution and freeze it to avoid repeated freeze-thaw cycles that may reduce activity. Suitable for in vitro cell experiments and in vivo animal pharmacological model studies.

P41 primarily targets the melanocortin receptor and participates in the regulation of melanocortin. It is an important tool peptide for receptor pharmacology and behavioral model studies. Animal experiments have shown that P41 acts on the hypothalamic receptor pathway, regulates neurotransmitter release, and affects related physiological signal transduction. It can be used to explore the endocrine regulatory mechanisms mediated by the melanocortin receptor family.

In pharmacological research models, this peptide is primarily used to validate the mechanism of action of receptor agonists, elucidate central signaling pathways, and conduct intervention experiments in behavioral animal models to study the chain reactions of downstream endocrine and neural signals after receptor activation. It is also used for early drug target screening, comparing differential biological responses after activation of different melanocortin receptor subtypes, and providing experimental support for early molecular validation of new drugs.

Limitations of this study include: existing experimental data mainly come from in vitro cell and animal models, with limited large-sample human clinical data; the experimental effects of this peptide show significant dose-dependency; different routes of administration and animal species lead to different experimental results; the research procedure must include blank controls and gradient dose control groups; and various claims in the market regarding P41's improvement of human physiological function are exaggerated and exceed the scope of scientific literature.

In summary, P41 possesses the property of activating melanocortin receptors and is mainly used in basic research fields such as melanocortin receptor pharmacology and behavioral physiology. It is a commonly used tool and raw material in receptor pharmacology laboratories and has high research value in target validation and early development of lead compounds.